Cross-reactivity to low-risk genotypes
|
1
|
Grade 2
|
Atypical
|
70, 71, 81, 84
|
Positive (cross-reacting), 9.55
|
Negative
|
Positive (cross-reacting), 3.44
|
2
|
Grade 2
|
Normal
|
53, 66, 83
|
Positive (cross-reacting), 3.58
|
Positive, other high-risk genotypes: 30.1
|
Negative
|
3
|
Grade 3
|
Low-grade
|
82
|
Positive (cross-reacting), 2.70
|
Positive (cross-reacting), genotype 16: 37.3
|
Negative
|
4
|
Grade 3
|
High-grade
|
42, 61
|
Positive (cross-reacting), 5.74
|
Negative
|
Negative
|
5
|
Grade 3
|
High-grade
|
82
|
Positive (cross-reacting), 11.06
|
Negative
|
Negative
|
6
|
Cervical cancer
|
High-grade
|
70
|
Positive (“cross-reacting”), 21.43
|
Positive (“cross-reacting”), genotype 18: 39.5
|
Positive (“cross-reacting”), 0.84
|
Cross-reactivity to unconfirmed genotypes
|
7
|
Grade 3
|
Atypical
|
None
|
Positive (CLART negative), 2.14
|
Positive (CLART negative), other high-risk genotypes: 34.0
|
Positive (CLART negative), 14.92
|